Delivery Order SPE2DB20D3103-SPE2DB23FP2Z3
Award Date
8/8/23
Potential Completion Date
8/29/23
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of 4,554,344,151 units of the pharmaceutical product PROQUAD VIALS. The contract has a ceiling value of $4,158.45 and a completion date of August 25, 2021. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on May 6, 2024 with a ceiling value of $12,564.32. The contract is a Firm Fixed Price Delivery Order with a completion date of May 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and has an Indefinite Delivery...
This federal contract award is for the procurement of PROQUAD VIALS by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,249.70, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on January 31, 2024. The contract has a completion date of February 22, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $10,371.72 and is a firm fixed-price delivery order contract that runs through January 3, 2025. The contract was awarded on December 11, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a key...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROQUAD VIALS. The contract has a ceiling value of $1,386.15 and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a...
This federal contract award is for the delivery of PROQUAD VIALS to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $3,203.98 and a completion date of July 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $12,964.60 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with an ultimate completion date of December 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $3,203.98 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is part of a larger...
This federal contract award, with a ceiling value of $2,772.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a period of performance through September 30, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in the distribution of pharmaceutical products and...
This federal contract award, valued at $34,653.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the delivery of PROQUAD VIALS. The award, which has a completion date of October 20, 2021, is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key supplier of pharmaceutical products...